Guidelines for the Management of Non-Transfusion-Dependent β-Thalassaemia (NTDT)

The 3rd edition of the Thalassaemia International Federation's Guidelines for the Management of Non-Transfusion-Dependent β-Thalassaemia (NTDT) is available. This updated edition is a valuable resource for enhancing the care of individuals with NTDT, a condition that has been underestimated regarding its importance and clinical significance for many years.

 

The 2023 version of the document details the most prominent pathophysiologic mechanisms and common clinical morbidities encountered in NTDT patients. It offers numerous updated, evidence-based recommendations within its 13 sections to keep clinicians worldwide informed on the evolving healthcare landscape.

 

These guidelines cater to a diverse audience, including primary care physicians, haematologists, cardiologists, endocrinologists, hepatologists, obstetricians, and other healthcare specialists involved in treating NTDT patients.

 

We encourage physicians and healthcare professionals engaged in thalassaemia patient care to utilize the book's contents and recommendations. Please help us disseminate this vital information to national competent authorities and healthcare professionals worldwide.